Cable Hill Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $481K | Sell |
2,447
-1,091
| -31% | -$212K | 0.05% | 92 |
|
|
2024
Q4 | $629K | Sell |
3,538
-444
| -11% | -$81.6K | 0.06% | 70 |
|
|
2024
Q3 | $786K | Sell |
3,982
-21
| -0.5% | -$3.92K | 0.08% | 60 |
|
|
2024
Q2 | $687K | Buy |
+4,003
| New | +$663K | 0.07% | 62 |
|
|
2023
Q4 | – | Sell |
-5,976
| Closed | -$891K | – | 97 |
|
|
2023
Q3 | $891K | Buy |
5,976
+140
| +2% | +$20.6K | 0.12% | 44 |
|
|
2023
Q2 | $786K | Buy |
5,836
+22
| +0.4% | +$3.23K | 0.1% | 48 |
|
|
2023
Q1 | $927K | Sell |
5,814
-1,160
| -17% | -$177K | 0.15% | 40 |
|
|
2022
Q4 | $1.13M | Sell |
6,974
-143
| -2% | -$21.9K | 0.2% | 40 |
|
|
2022
Q3 | $955K | Buy |
7,117
+176
| +3% | +$25.3K | 0.19% | 39 |
|
|
2022
Q2 | $1.06M | Buy |
6,941
+3,179
| +85% | +$486K | 0.27% | 37 |
|
|
2022
Q1 | $610K | Sell |
3,762
-82
| -2% | -$11.9K | 0.4% | 39 |
|
|
2021
Q4 | $520K | Sell |
3,844
-368
| -9% | -$43.5K | 0.11% | 76 |
|
|
2021
Q3 | $454K | Buy |
4,212
+150
| +4% | +$17.1K | 0.11% | 76 |
|
|
2021
Q2 | $458K | Sell |
4,062
-130
| -3% | -$14.6K | 0.11% | 74 |
|
|
2021
Q1 | $454K | Buy |
4,192
+290
| +7% | +$31K | 0.12% | 57 |
|
|
2020
Q4 | $418K | Sell |
3,902
-92
| -2% | -$8.84K | 0.11% | 59 |
|
|
2020
Q3 | $350K | Buy |
3,994
+329
| +9% | +$31K | 0.1% | 61 |
|
|
2020
Q2 | $360K | Buy |
3,665
+405
| +12% | +$35.7K | 0.12% | 52 |
|
|
2020
Q1 | $248K | Sell |
3,260
-224
| -6% | -$19.1K | 0.09% | 72 |
|
|
2019
Q4 | $308K | Sell |
3,484
-496
| -12% | -$41.2K | 0.09% | 72 |
|
|
2019
Q3 | $301K | Sell |
3,980
-825
| -17% | -$56.6K | 0.1% | 71 |
|
|
2019
Q2 | $349K | Sell |
4,805
-536
| -10% | -$42.1K | 0.12% | 69 |
|
|
2019
Q1 | $430K | Buy |
5,341
+4
| +0.1% | +$327 | 0.14% | 65 |
|
|
2018
Q4 | $492K | Buy |
5,337
+691
| +15% | +$60.8K | 0.2% | 43 |
|
|
2018
Q3 | $436K | Sell |
4,646
-15
| -0.3% | -$1.42K | 0.18% | 31 |
|
|
2018
Q2 | $432K | Sell |
4,661
-296
| -6% | -$28.9K | 0.18% | 29 |
|
|
2018
Q1 | $445K | Sell |
4,957
-4,365
| -47% | -$480K | 0.19% | 28 |
|
|
2017
Q4 | $926K | Buy |
9,322
+230
| +3% | +$21.7K | 0.4% | 17 |
|
|
2017
Q3 | $808K | Buy |
9,092
+6,378
| +235% | +$486K | 0.37% | 17 |
|
|
2017
Q2 | $197K | Buy |
2,714
+3
| +0.1% | +$202 | 0.11% | 56 |
|
|
2017
Q1 | $177K | Buy |
2,711
+186
| +7% | +$11.7K | 0.09% | 62 |
|
|
2016
Q4 | $158K | Buy |
2,525
+2
| +0.1% | +$122 | 0.07% | 65 |
|
|
2016
Q3 | $158K | Buy |
2,523
+1,210
| +92% | +$78.3K | 0.11% | 64 |
|
|
2016
Q2 | $83K | Buy |
1,313
+87
| +7% | +$5.3K | 0.06% | 91 |
|
|
2016
Q1 | $71K | Buy |
1,226
+200
| +19% | +$11.1K | 0.05% | 88 |
|
|
2015
Q4 | $62K | Buy |
1,026
+300
| +41% | +$17.3K | 0.04% | 111 |
|
|
2015
Q3 | $41K | Hold |
726
| – | – | 0.03% | 147 |
|
|
2015
Q2 | $51K | Sell |
726
-100
| -12% | -$6.53K | 0.04% | 133 |
|
|
2015
Q1 | $48K | Hold |
826
| – | – | 0.04% | 136 |
|
|
2014
Q4 | $54K | Buy |
+826
| New | +$52.1K | 0.05% | 123 |
|
Other funds holding ABBV
Cable Hill Partners's ABBV Position: Q1 2025 in Review
Cable Hill Partners reduced its AbbVie (ABBV) stake by 31% in Q1 2025, selling an estimated $212K and leaving 2,447 shares worth $481K. The position accounts for 0.05% of the portfolio, ranked #92.
Cable Hill Partners first reported a position in ABBV in Q4 2014 and has held it in 40 quarters since. The position peaked at $1.13M in Q4 2022. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.
- Cable Hill Partners held 2,447 shares of AbbVie worth $481K as of Q1 2025.
- Cable Hill Partners sold 1,091 AbbVie shares in Q1 2025, an estimated $212K.
- AbbVie made up 0.05% of Cable Hill Partners's portfolio in Q1 2025, its #92 holding.
- Cable Hill Partners first reported a position in AbbVie in Q4 2014 and has held it in 40 quarters since.
- Cable Hill Partners's AbbVie position peaked at $1.13M in Q4 2022.
- 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.
Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.